Follow
Bruce Baguley
Bruce Baguley
Emeritus Distinguished Professor, the University of Auckland
Verified email at auckland.ac.nz
Title
Cited by
Cited by
Year
Disrupting tumour blood vessels
GM Tozer, C Kanthou, BC Baguley
Nature Reviews Cancer 5, 423-435, 2005
11382005
Signaling pathways in melanogenesis
SAN D’Mello, GJ Finlay, BC Baguley, ME Askarian-Amiri
International journal of molecular sciences 17 (7), 1144, 2016
9902016
Quenching of DNA-ethidium fluorescence by amsacrine and other antitumor agents: a possible electron-transfer effect
BC Baguley, M Le Bret
Biochemistry 23 (5), 937-943, 1984
6621984
Multiple drug resistance mechanisms in cancer
BC Baguley
Molecular biotechnology 46, 308-316, 2010
6432010
Potential antitumor agents. 59. Structure-activity relationships for 2-phenylbenzimidazole-4-carboxamides, a new class of ‘minimal’ DNA-intercalating agents which may not act …
WA Denny, GW Rewcastle, BC Baguley
Journal of Medicinal Chemistry 33, 814-819, 1990
4381990
Epigenetic regulation in human melanoma: past and future
D Sarkar, EY Leung, BC Baguley, GJ Finlay, ME Askarian-Amiri
Epigenetics 10 (2), 103-121, 2015
2982015
Potential antitumor agents. 50. In vivo solid tumor activity of derivatives of N[2-(dimethylamino)ethyl]-acridine 4-carboxamide
GJ Atwell, GW Rewcastle, BC Baguley, D WA
vivo 30, 664-669, 1987
2751987
Potential antitumor agents. Part 34. Quantitative relationships between DNA binding and molecular structure for 9-anilinoacridines substituted in the anilino ring
BC Baguley, WA Denny, GJ Atwell, BF Cain
Journal of Medicinal Chemistry 24, 170-177, 1981
2661981
Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids
GW Rewcastle, GJ Atwell, L Zhuang, BC Baguley, WA Denny
Journal of medicinal chemistry 34 (1), 217-222, 1991
2651991
A semiautomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells
GJ Finlay, BC Baguley, WR Wilson
Anal Biochem 139, 272-277, 1984
2611984
Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes
MJ McKeage, SJ Berners-Price, P Galettis, RJ Bowen, W Brouwer, L Ding, ...
Cancer chemotherapy and pharmacology 46, 343-350, 2000
2592000
Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs
D Screnci, MJ McKeage, P Galettis, TW Hambley, BD Palmer, BC Baguley
British journal of cancer 82 (4), 966-972, 2000
2472000
DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove-targeted aniline mustard analogs of pibenzimol (Hoechst 33258)
GL Gravatt, BC Baguley, WR Wilson, WA Denny
Journal of medicinal chemistry 37 (25), 4338-4345, 1994
2431994
Potential antitumor agents. 28. Deoxyribonucleic acid polyintercalating agents
BF Cain, BC Baguley, WA Denny
Journal of Medicinal Chemistry 21, 658-668, 1978
2411978
Antivascular therapy of cancer: DMXAA
BC Baguley
The lancet oncology 4 (3), 141-148, 2003
2372003
In vitro antitumour and hepatotoxicity profiles of Au(I) and Ag(I) bidentate pyridyl phosphine complexes and relationships to uptake.
JJ Liu, P Galettis, A Farr, L Maharaj, H Samarasinha, AC McGechan, ...
Journal of Inorganic Biochemistry 102, 303-310, 2008
2342008
Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism
BC Baguley, KM Holdaway, LL Thomsen, L Zhuang, LJ Zwi
European Journal of Cancer and Clinical Oncology 27 (4), 482-487, 1991
2331991
Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA)
CJ Portier, BK Armstrong, BC Baguley, X Baur, I Belyaev, R Bellé, ...
J Epidemiol Community Health 70 (8), 741-745, 2016
2282016
The interaction of ethidium with synthetic double-stranded polynucleotides at low ionic strength
BC Baguley, EM Falkenhaug
Nucleic Acids Research 5 (1), 161-171, 1978
2251978
Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma
CE Burd, W Liu, MV Huynh, MA Waqas, JE Gillahan, KS Clark, K Fu, ...
Cancer discovery 4 (12), 1418-1429, 2014
2232014
The system can't perform the operation now. Try again later.
Articles 1–20